4
Changes in Ownership
LISATA THERAPEUTICS, INC. Filed Acc 0001879231-22-000002
EVP, R&D and CMO gave up 7,694 shares (to pay taxes)
- EVP, R&D and CMO acquired 64,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Buck Kristen K · EVP, R&D and CMO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-10 | Grant or award : show line 1 in the form | +64,500 | 326,897 | D | ||
| 2022-01-10 | Shares withheld for taxes : show line 2 in the form | −7,694 | $0.92 | $7,055 | 319,203 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-10 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +32,500 | 32,500 | D |
Loading xslF345X03/wf-form4_164202231648913.xml…